Varex Imaging (VREX) Projected to Post Earnings on Thursday

Varex Imaging (NASDAQ:VREX) will likely be posting its Q2 2026 results after the market closes on Thursday, May 7th. Analysts expect Varex Imaging to post earnings of $0.22 per share and revenue of $216.9170 million for the quarter. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. Individuals may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.05. The firm had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Price Performance

VREX traded up $0.22 on Wednesday, reaching $11.75. 23,301 shares of the company’s stock were exchanged, compared to its average volume of 308,593. The stock has a market cap of $492.33 million, a PE ratio of -7.17 and a beta of 0.96. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $14.56. The stock’s fifty day moving average price is $11.60 and its 200-day moving average price is $12.17. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.89 and a quick ratio of 1.87.

Insider Activity at Varex Imaging

In other news, Director Jay K. Kunkel sold 4,510 shares of the company’s stock in a transaction on Friday, March 20th. The stock was sold at an average price of $11.14, for a total value of $50,241.40. Following the transaction, the director owned 23,450 shares of the company’s stock, valued at $261,233. This represents a 16.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Varex Imaging

Several large investors have recently modified their holdings of VREX. Quarry LP acquired a new position in shares of Varex Imaging in the 3rd quarter valued at $64,000. BNP Paribas Financial Markets lifted its holdings in shares of Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after acquiring an additional 2,036 shares during the last quarter. Aquatic Capital Management LLC acquired a new position in shares of Varex Imaging in the 3rd quarter worth approximately $117,000. Cerity Partners LLC acquired a new position in shares of Varex Imaging in the 2nd quarter worth approximately $123,000. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after acquiring an additional 1,442 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Jefferies Financial Group restated a “hold” rating and set a $14.50 price target on shares of Varex Imaging in a research report on Monday, February 2nd. B. Riley Financial reissued a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. Wall Street Zen lowered Varex Imaging from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 25th. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. Finally, Zacks Research raised Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Varex Imaging presently has an average rating of “Moderate Buy” and a consensus price target of $16.17.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.